These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment. Perez-Garcia J; González-Carracedo M; Espuela-Ortiz A; Hernández-Pérez JM; González-Pérez R; Sardón-Prado O; Martin-Gonzalez E; Mederos-Luis E; Poza-Guedes P; Corcuera-Elosegui P; Callero A; Sánchez-Machín I; Korta-Murua J; Pérez-Pérez JA; Villar J; Pino-Yanes M; Lorenzo-Diaz F J Allergy Clin Immunol; 2023 Mar; 151(3):706-715. PubMed ID: 36343772 [TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220 [TBL] [Abstract][Full Text] [Related]
25. Oral dysbiosis and its linkage with SARS-CoV-2 infection. Gupta A; Bhanushali S; Sanap A; Shekatkar M; Kharat A; Raut C; Bhonde R; Shouche Y; Kheur S; Sharma A Microbiol Res; 2022 Aug; 261():127055. PubMed ID: 35597076 [TBL] [Abstract][Full Text] [Related]
26. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection. Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134 [TBL] [Abstract][Full Text] [Related]
27. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy. Giugliano R; Sellitto A; Ferravante C; Rocco T; D'Agostino Y; Alexandrova E; Lamberti J; Palumbo D; Galdiero M; Vaccaro E; Pagliano P; Weisz A; Giurato G; Franci G; Rizzo F Microb Pathog; 2022 Apr; 165():105506. PubMed ID: 35358660 [TBL] [Abstract][Full Text] [Related]
28. The nasal microbiome in asthma. Fazlollahi M; Lee TD; Andrade J; Oguntuyo K; Chun Y; Grishina G; Grishin A; Bunyavanich S J Allergy Clin Immunol; 2018 Sep; 142(3):834-843.e2. PubMed ID: 29518419 [TBL] [Abstract][Full Text] [Related]
29. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients. Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467 [TBL] [Abstract][Full Text] [Related]
30. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19. Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058 [TBL] [Abstract][Full Text] [Related]
31. Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection. Crovetto F; Selma-Royo M; Crispi F; Carbonetto B; Pascal R; Larroya M; Casas I; Tortajada M; Escudero N; Muñoz-Almagro C; Gomez-Roig MD; González-Torres P; Collado MC; Gratacos E Sci Rep; 2022 Aug; 12(1):13404. PubMed ID: 35927569 [TBL] [Abstract][Full Text] [Related]
32. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients. Alexander JL; Mullish BH; Danckert NP; Liu Z; Olbei ML; Saifuddin A; Torkizadeh M; Ibraheim H; Blanco JM; Roberts LA; Bewshea CM; Nice R; Lin S; Prabhudev H; Sands C; Horneffer-van der Sluis V; Lewis M; Sebastian S; Lees CW; Teare JP; Hart A; Goodhand JR; Kennedy NA; Korcsmaros T; Marchesi JR; Ahmad T; Powell N EBioMedicine; 2023 Feb; 88():104430. PubMed ID: 36634565 [TBL] [Abstract][Full Text] [Related]
33. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562 [TBL] [Abstract][Full Text] [Related]
34. Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing. Rueca M; Fontana A; Bartolini B; Piselli P; Mazzarelli A; Copetti M; Binda E; Perri F; Gruber CEM; Nicastri E; Marchioni L; Ippolito G; Capobianchi MR; Di Caro A; Pazienza V Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672177 [TBL] [Abstract][Full Text] [Related]
35. Feasibility of using alternative swabs and storage solutions for paired SARS-CoV-2 detection and microbiome analysis in the hospital environment. Minich JJ; Ali F; Marotz C; Belda-Ferre P; Chiang L; Shaffer JP; Carpenter CS; McDonald D; Gilbert J; Allard SM; Allen EE; Knight R; Sweeney DA; Swafford AD Microbiome; 2021 Jan; 9(1):25. PubMed ID: 33482920 [TBL] [Abstract][Full Text] [Related]
36. Sex effects in the association between airway microbiome and asthma. Chen R; Wang L; Koch T; Curtis V; Yin-DeClue H; Handley SA; Shan L; Holtzman MJ; Castro M; Wang L Ann Allergy Asthma Immunol; 2020 Dec; 125(6):652-657.e3. PubMed ID: 32931909 [TBL] [Abstract][Full Text] [Related]
37. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome. Wang Y; Wu G; Zhao L; Wang W mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129 [TBL] [Abstract][Full Text] [Related]
38. Dysbiosis of Oral and Gut Microbiomes in SARS-CoV-2 Infected Patients in Bangladesh: Elucidating the Role of Opportunistic Gut Microbes. Rafiqul Islam SM; Foysal MJ; Hoque MN; Mehedi HMH; Rob MA; Salauddin A; Tanzina AY; Biswas S; Noyon SH; Siddiki AMAMZ; Tay A; Mannan A Front Med (Lausanne); 2022; 9():821777. PubMed ID: 35237631 [TBL] [Abstract][Full Text] [Related]